New Research Finds Promise in Psychiatric Use Of Psilocybin North American Companies Explore Full Potential
(MENAFN - Baystreet.ca) A new study led by the Imperial College London's Centre for Psychedelic Research has yielded promising results for the use of psilocybin in psychiatric therapy. Psilocybin, the psychoactive compound of magic mushrooms - was pitted up against popular SSRI (selective serotonin reuptake inhibitor) escitalopram. Results were measured through scoring tallied after surveying participants on their sleep, energy, appetite, mood and suicidal ideations. The largely-negatively focused questionnaire attained similar results for both the SSRI and the psilocybin group - an alre...